{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["71(10)"],"submitter":["Masa JF"],"pubmed_abstract":["<h4>Background</h4>Non-invasive ventilation (NIV) is an effective form of treatment in patients with obesity hypoventilation syndrome (OHS) who have concomitant severe obstructive sleep apnoea (OSA). However, there is a paucity of evidence on the efficacy of NIV in patients with OHS without severe OSA. We performed a multicentre randomised clinical trial to determine the comparative efficacy of NIV versus lifestyle modification (control group) using daytime arterial carbon dioxide tension (PaCO2) as the main outcome measure.<h4>Methods</h4>Between May 2009 and December 2014 we sequentially screened patients with OHS without severe OSA. Participants were randomised to NIV versus lifestyle modification and were followed for 2 months. Arterial blood gas parameters, clinical symptoms, health-r"],"journal":["Thorax"],"pagination":["899-906"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC5036235"],"repository":["biostudies-literature"],"pubmed_title":["Non-invasive ventilation in obesity hypoventilation syndrome without severe obstructive sleep apnoea."],"pmcid":["PMC5036235"],"pubmed_authors":["Ojeda E","Gonzalez M","Sancho-Chust JN","Caballero C","Gallego B","Egea C","Alonso-Alvarez ML","Marin JM","Teran-Santos J","Spanish Sleep Network","Martinez-Martinez MA","Munoz-Mendez J","Ramon MA","Senent C","Masa JF","Chiner E","Carrizo SJ","Corral J","Gomez-Garcia T","Diaz-Cambriles T","Ordax E","Golpe R","Barrot E","Marti S","Garcia-Ledesma E","Sanchez-Gomez J","Mokhlesi B","Ribas-Solis FJ","Romero A","Lopez-Martin S","Bengoa M","Cantalejo O","Benitez JM","Gonzalez-Mangado N","Diaz-de-Atauri J","Troncoso MF","Sanchez-Quiroga MA","De Lucas P","Gomez S","Pallero M","Miranda E","Santiago-Recuerda A"],"additional_accession":[]},"is_claimable":false,"name":"Non-invasive ventilation in obesity hypoventilation syndrome without severe obstructive sleep apnoea.","description":"<h4>Background</h4>Non-invasive ventilation (NIV) is an effective form of treatment in patients with obesity hypoventilation syndrome (OHS) who have concomitant severe obstructive sleep apnoea (OSA). However, there is a paucity of evidence on the efficacy of NIV in patients with OHS without severe OSA. We performed a multicentre randomised clinical trial to determine the comparative efficacy of NIV versus lifestyle modification (control group) using daytime arterial carbon dioxide tension (PaCO2) as the main outcome measure.<h4>Methods</h4>Between May 2009 and December 2014 we sequentially screened patients with OHS without severe OSA. Participants were randomised to NIV versus lifestyle modification and were followed for 2 months. Arterial blood gas parameters, clinical symptoms, health-r","dates":{"release":"2016-01-01T00:00:00Z","publication":"2016 Oct","modification":"2026-06-08T06:48:23.324Z","creation":"2026-06-08T03:14:04.911Z"},"accession":"S-EPMC5036235","cross_references":{"pubmed":["27406165"],"doi":["10.1136/thoraxjnl-2016-208501"]}}